These stimulatory effects of both IL-1 and IL-23 on IL-17A production were already demonstrated in vitro (Sutton et al., 2009), and our data clearly suggest that both pathways participate in γδ T cell activation following ischemic stroke in vivo. This evidence concerns the gene IL17A and ischemic stroke.